Skip to main content
PhRMA.org Logo
  • About
  • Policy Issues
  • Scientific Innovation
  • Patient Support
  • News
  • Resources
  • Blog
Sites
  • Innovation.org
  • MAT.org
  • PhRMA.org
Exit Search
PhRMA.org Logo
Exit Search
  • About
  • Policy Issues
  • Scientific Innovation
  • Patient Support
  • News
  • Resources
  • Blog
  • Sites
  • Innovation.org
  • MAT.org
  • PhRMA.org

Search in PhRMA

  • All
  • News
  • Resources
  • Blogs
Search

News Room

New Ipsos Poll Shows Americans Are Frustrated with Abusive Insurance Practices That Exacerbate Access and Affordability Challenges

Graphic of two speech bubbles with three dots in each

Americans overwhelmingly say they are frustrated with health insurance coverage that is difficult to navigate and unaffordable.

Read More
Graphic of two speech bubbles with three dots in each
Recent Press Releases
Not Found
Search Results for ""
  • refreshdiseases
    Hepatitis C
  • refreshdiseases
    Cancer
  • refreshdiseases
    Mental Health
  • refreshdiseases
    Cardiovascular Disease
  • refreshdiseases
    Alzheimers Disease
  • refreshdiseases
    Osteoporosis
  • refreshdiseases
    Rheumatoid Arthritis
  • refreshdiseases
    COPD
  • refreshdiseases
    Parkinsons Disease
  • refreshdiseases
    Neurological Disorders
  • refreshdiseases
    Ebola
  • refreshdiseases
    Diabetes
  • refreshdiseases
    Heart Disease and Stroke
  • refreshdiseases
    COVID-19
  • refreshdiseases
    HIV AIDs
  • refreshdiseases
    Asthma
  • refreshdiseases
    Rare Diseases
  • refreshdiseases
    Chronic Disease
  • refreshdiseases
    Multiple Sclerosis
  • refreshtopics
    Sign Up
  • refreshtopics
    Speeches
  • refreshtopics
    Codes and Guidelines
  • refreshtopics
    Terms of Service
  • refreshtopics
    Contact Us
  • refreshtopics
    Privacy Policy
  • refreshtopics
    Leaders
  • refreshtopics
    Mission
  • refreshtopics
    Members
  • refreshtopics
    Health Coverage Hurdles
  • refreshtopics
    Search
  • refreshtopics
    About
  • refreshtopics
    Insurance Coverage
  • refreshtopics
    Medicine Safety
  • refreshtopics
    PDUFA
  • refreshtopics
    Importation
  • refreshtopics
    Advances in Treatment
  • refreshtopics
    Medicines in Development
  • refreshtopics
    Intellectual Property
  • refreshtopics
    Part B
  • refreshtopics
    Events
  • refreshtopics
    Better Way
  • refreshtopics
    Resources
  • refreshtopics
    Access to Medicines
  • refreshtopics
    Part D
  • refreshtopics
    Personalized Medicine
  • refreshtopics
    AMR
  • refreshtopics
    Innovation
  • refreshtopics
    Digital
  • refreshtopics
    Coronavirus
  • refreshtopics
    Medicaid
  • refreshtopics
    Equity
  • refreshtopics
    340B
  • refreshtopics
    Cost and Value
  • refreshtopics
    International
  • refreshtopics
    Trade
  • refreshtopics
    Report
  • refreshtopics
    Stem
  • refreshtopics
    Research and Development
  • refreshtopics
    Research in Your Backyard
  • refreshtopics
    Patients
  • refreshtopics
    Science
  • refreshtopics
    Clinical Trials
  • refreshtopics
    Disease
  • refreshtopics
    Value-Driven Health Care
  • refreshtopics
    Medicare
  • refreshtopics
    Patient Assistance
  • refreshtopics
    PhRMA Membership
  • refreshtopics
    Adherence
  • refreshtopics
    Economic Impact
  • refreshtopics
    Biologic and Biosimilars
  • refreshtopics
    Biomarkers
  • refreshtopics
    FDA
{count} Resources found
Not Found
Viewing {showCount} of {count} results
PhRMA.org Logo

PhRMA.Org is now loading ...

Stay Connected

Share

PhRMA Foundation logo
The Voters for Cures logo - Voters for Cures - an initiative from PhRMA
Medicine Assistance Tool logo

  • Members Site
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Site Map

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."